Daniel de Roulet

Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA.

Delpor, Inc. develops therapeutic products. Its products include DLP-114, DLP-119, DLP-202 and DLP-414. The company was founded by Tassos Nicolaou and Frank Martin in 2009 and is headquartered in San Francisco, CA.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Brookes & Gatehouse Ltd. is an electronics firm. The firm designs and manufactures navigational equipment, instruments, autopilots and other technological products. The company was founded by R.N. Gatehouse in 1955 and is headquartered in Romsey, the United Kingdom.

Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York.

Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.

Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California.

Part of University of California, California Institute For Quantitative Biosciences is a biotech company that offers internships to UC students through its state-funded Qwest internship program. The company is based in San Francisco, CA and was founded in 2000. The program places students with Bakar Labs tenant companies for work experience, and four of its first cohort have already received full-time job offers from their hosts. The company conducts proof-of-concept experiments in a mouse model of ALS and offers mentoring programs to early-stage companies.

Reflexion Medical, Inc. develops medical devices. Its products include marketwired resonate and influencers, news distribution, IR and PR hosted newsroom and media database. The company was founded by Akshay Nanduri and Samuel Mazin in 2009 and is headquartered in Hayward, CA.

BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts.

Tangible Science, Inc. manufactures contact lenses and provides eye care services. It develops a novel polymer based coating technology for use in contact lenses to treat dry eye disease. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Karen Havenstrite, Victor W. McCray, and Garrett Cale Smith in 2011 and is headquartered in Redwood City, CA.

Zephyrus Biosciences, Inc. provides tools for protein analysis at the single cell level. The firm's products include Z1 instrument, zWest Kits, and scWestern system which enables western blotting on individual cells. Its products are used to gain insights into the biology of cancer, stem cells, neurology, and human disease and development. The company was founded by Kelly Gardner, Amy E. Herr and Joshua Molho in 2013 and is headquartered in Berkeley, CA.

Circle Pharma, Inc. provides biotechnology services. The company was founded by Matthew P. Jacobson and Scott Lokey in June 2014 and is headquartered in San Francisco, CA.

SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT.

Magnap, Inc. provides surgical devices to prevent airway collapse during sleep. The company is headquartered in San Francisco, CA.

Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA.

Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA.

Invenio Imaging, Inc. provides treatment for cancer through label-free chemical imaging and fiber-laser technology. Its NIO Imaging System is designed to streamline intraoperative histology, reducing downtime in the OR and allowing examination of specimens from multiple sites in the surgical cavity. The company was founded in 2012 and is headquartered in Santa Clara, CA.

Epiodyne, Inc. engages in biotechnology services. The company was founded by Brian Shoichet, Brian Kobilka, Peter Gmeiner, Bryan L. Roth, Gregory Scherrer, and Aashish Manglik in 2016 and is headquartered in San Francisco, CA.

ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX.

Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France.

Graphwear Technologies, Inc. develops software and wearable devices for dehydration monitoring. It specializes in wearable sensors, nanotechnology, non-invasive healthcare monitoring and preventive healthcare. The company was founded by Saurabh Radhakrishnan and Rajatesh Gudibande and is headquartered in San Francisco, CA.

Alessa Therapeutics, Inc. develops localized treatments for solid organ disease. The company was founded by Pamela Munster and Scott Thomas and is headquartered in San Carlos, CA.

Telo Therapeutics, Inc. develops precision medicines to reverse cancer cell immortality.

Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium.

BioInnovation LLC is a Angel firm, a subsidiary of BioInnovation LLC founded in 2018. BioInnovation LLC is headquartered in Cambridge.

Avexegen Therapeutics, Inc. develops novel and revolutionary therapies for inflammatory bowel disease. The company is based in San Diego, CA. The CEO of the company is Artin Asadourian.